Novo Nordisk's FDA-approved Wegovy pill marks a new era in obesity treatment, expanding access to GLP-1 therapy through affordable oral medication.

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like...

Employers gain access to comprehensive cardiometabolic care and cost-effective GLP-1 for obesity management coverage ......

Employers gain access to comprehensive cardiometabolic care and cost-effective GLP-1 for obesity management coverage ......

GLP-1 medications like Ozempic and Wegovy have transformed obesity treatment, but maintaining weight loss after the medications stop remains a...

In recent years, new weight-loss drugs have become very popular. These medicines, known as GLP-1 agonists, are injectables that help people feel less...

Taking a weight loss drug based on glucagon-like peptide-1 (GLP-1) such as Ozempic successfully helped an individual lose up to 20% of their weight...

It is well known that obesity typically leads to inflammation and dysfunction of fat tissue that increases the risk of developing metabolic diseases...